Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Vet Immunol Immunopathol ; 157(3-4): 164-74, 2014 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-24445196

RESUMO

Rhodococcus equi is the most common infectious cause of mortality in foals between 1 and 6 months of age. Because of an increase in the number of antibiotic-resistant strains, the optimization of a prophylactic strategy is a key factor in the comprehensive management of R. equi pneumonia. The objectives of this study were to assess the safety and immunogenicity of R. equi-secreted proteins (ReSP) co-administered with either the nanoparticular adjuvant Montanide™ IMS 3012 VG, or a new polymeric adjuvant Montanide™ PET GEL A, and to further investigate the most immunogenic proteins for subsequent immunization/challenge experiments in the development of a vaccine against rhodoccocal pneumonia. The approach involved two phases. The first phase aimed to investigate the safety of vaccination in six adult horses. The second phase aimed to determine the safety and immunogenicity of vaccination in twelve 3-week-old foals. We set out to develop a method based on ultrasound measurements for safety assessment in adult horses in order to evaluate any in situ changes at the injection site, in the skin or the underlying muscle, with quantitative and qualitative data revealing that administration of ReSP combined with the Pet Gel A adjuvant led to an increase in local inflammation, associated with 4- to 7-fold higher levels of anti-R. equi IgGa, IgGb and IgGT, compared to administration of ReSP associated with IMS 3012 adjuvant, but without any impact on animal demeanor. Investigations were then performed in foals with serological and clinical follow-up until 6 months of age. Interestingly, we observed in foals a much lower incidence of adverse local tissue reactions at the injection site than in adult horses, with transient and moderate swelling for the group that received ReSP combined with Pet Gel A. Immunized foals with Pet Gel A adjuvant exhibited a similar response in both IgGa and IgGT levels, but a lower response in IgGb levels, compared to adult horses, with a subisotype profile that may however reflect a bias favorable to R. equi resistance. From the crude extract of secreted proteins, dot-blot screening enabled identification of cholesterol oxidase, mycolyl transferase 3, and PSP (probable secreted protein) as the most immunogenic candidates. Taken together, these results are encouraging in developing a vaccine for foals.


Assuntos
Proteínas de Bactérias/imunologia , Vacinas Bacterianas/imunologia , Rhodococcus equi/imunologia , Adjuvantes Imunológicos/administração & dosagem , Animais , Vacinas Bacterianas/efeitos adversos , Cavalos , Imunoglobulina G/sangue , Imunoglobulina G/classificação , Nanopartículas/administração & dosagem , Polímeros/administração & dosagem
2.
Presse Med ; 31(2): 58-63, 2002 Jan 19.
Artigo em Francês | MEDLINE | ID: mdl-11850986

RESUMO

OBJECTIVES: Since April 1999, we have set-up an infectious disease consultation in the emergency unit of the University Hospital in Nice. Unjustified antiobiotherapy is often initiated. We therefore conducted a survey to study the motives and validity of antibiotic prescriptions. METHOD: This prospective study was conducted in two phases. The first consisted in asking the emergency physicians prescribing antibiotics to fill-in a questionnaire giving information on the diagnosis established and the antiobiotherapy proposed. In the second phase, the diagnoses and corresponding treatments were submitted to 4 experts who assessed the acceptability of the diagnoses and the antibiotics prescribed. The experts only had access to the clinical and para-clinical data available. Moreover, their therapeutic judgement was based on previously published consensuses. RESULTS: The 6-month survey collected 117 questionnaires that could be analysed. The rate of error in diagnosis was of 33% (39/117). Thoracic x-rays could not be interpreted in 11% of cases. In single variant analysis, factors of erroneous diagnosis were due to its interpretation by an internist, the diagnostic category of "broncho-pulmonary infections" and the lack of documentation. In multi variant analysis, only the lack of documentation was related to erroneous diagnosis (OR = 5.5; IC 95% (2.03; 15.30), p < 0.0002). The rate of antibiotherapy not adapted to the diagnosis made by the physician was of 32% (37/117). In 24 cases the modalities of the prescription were incorrect and in 13 cases the prescription was unjustified. Only the status of the prescriber (internist) was statistically associated with an antibiotherapy not adapted to the diagnosis (OR = 2.2; IC 95% (0.93; 5.26), p < 0.05). CONCLUSION: Unjustified antibiotherapy in an emergency unit is generally due to erroneous diagnosis of infection. The lack of documentation and inexperience of the prescribers appear to be the two elements contributing to unjustified antibiotherapy.


Assuntos
Antibacterianos/uso terapêutico , Erros de Diagnóstico , Prescrições de Medicamentos , Serviço Hospitalar de Emergência , Hospitais Universitários , Interpretação Estatística de Dados , França , Humanos , Modelos Logísticos , Análise Multivariada , Razão de Chances , Estudos Prospectivos , Inquéritos e Questionários
3.
Rev Belge Med Dent (1984) ; 57(3): 206-14, 2002.
Artigo em Francês | MEDLINE | ID: mdl-12508720

RESUMO

An epidemiological survey was carried out of among staff members of the Catholic University of Louvain. A total of 402 subjects, age 35 to 65, were examined. Periodontal lesions were estimated using the CPITN index (WHO). Only one subject presented no signs of gingival bleeding in any part of the mouth. 41.4% of the subjects presented a deep periodontal pocket in at least one sextant. Many subjects, although not presenting deep or moderately deep periodontal pockets (28.5%) needed scaling and rootplanning or other treatments to eliminate plaque retentive factors. In this sample, representing a socio-economically favoured segment of the population, we revealed a significant prevalence of periodontal disease from mild chronic gingivitis to deep pockets. Requirements in terms of care are considerable, ranging from oral hygiene instruction to control plaque to specialised care.


Assuntos
Doenças Periodontais/epidemiologia , Adulto , Idoso , Bélgica/epidemiologia , Estudos Transversais , Placa Dentária/epidemiologia , Feminino , Necessidades e Demandas de Serviços de Saúde/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Higiene Bucal/estatística & dados numéricos , Índice Periodontal , Bolsa Periodontal/epidemiologia , Prevalência , Inquéritos e Questionários
4.
Age Ageing ; 21(6): 456-62, 1992 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1281961

RESUMO

To assess the clinical value of urinary trypsin inhibitory activity (UTIA) in elderly people, a prospective study was carried out over 4 months in our internal medicine department. Two hundred and forty-three patients of more than 60 years of age were included. A positive correlation was observed between UTIA and serum creatinine (p < 10(-3)). In the population with serum creatinine of less than 133 mumol/l (200 patients), UTIA was independent of age, sex and serum creatinine. UTIA was compared with seven serum inflammatory proteins titrated on patient admission. The principal interest of UTIA determination appeared in bacterial infections. UTIA was significantly increased in this group (p < 10(-4)). However, a positive correlation was proved only with C-reactive protein (CRP) (p = 9 x 10(-4)). Nevertheless, CRP appeared to be the best marker of bacterial infectious diseases after receiver operating characteristic curves analysis.


Assuntos
Reação de Fase Aguda/diagnóstico , Infecções Bacterianas/diagnóstico , Inibidores da Tripsina/urina , Infecções Urinárias/diagnóstico , Proteínas de Fase Aguda/urina , Reação de Fase Aguda/urina , Idoso , Idoso de 80 Anos ou mais , Infecções Bacterianas/urina , Diagnóstico Diferencial , Feminino , Febre de Causa Desconhecida/etiologia , Humanos , Testes de Função Renal , Masculino , Estudos Prospectivos , Curva ROC , Infecções Urinárias/urina
5.
Biol Neonate ; 55(1): 10-8, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2650741

RESUMO

Perinatal mortality in Belgium remains high compared with other countries of Western Europe, although a marked decrease was observed during the period from 1956 to 1984. Analysis of the death causes indicates that further progress is feasible. Social inequalities and geographic variation are persisting in spite of the long-established policy of social welfare and free access to health services. Most of the studies on perinatal mortality in Belgium are descriptive and based on data recorded in birth and infant death certificates. In the future, alternative sources of information should be used to analyze more precisely and to understand more clearly the interactions between the different determinants of perinatal mortality and to evaluate the impact of social and health services.


Assuntos
Mortalidade Infantil , Bélgica , Humanos , Mortalidade Infantil/tendências , Recém-Nascido de Baixo Peso , Recém-Nascido , Recém-Nascido Prematuro , Fatores de Risco , Estatística como Assunto
6.
Rev Epidemiol Sante Publique ; 36(4-5): 273-82, 1988.
Artigo em Francês | MEDLINE | ID: mdl-3146112

RESUMO

The EUROCAT programme is a concerted action of the European Economic Community for the epidemiologic surveillance of congenital anomalies. Surveillance is based on a network of regional registries coordinated by a central registry. The programme started in 1979 and by 1987, 23 centres were participating, covering together more than 300,000 births per year. The surveillance process implies the selection of the anomalies possibly associated with environmental teratogens or mutagens, the definition of abnormal variations in the rate of these anomalies (the alarms), the establishment of base-line rate and the continuous monitoring of rate. The programme is evaluated by reference to four criteria: the sensitivity of the system in detecting teratogens or mutagens, the specificity of alarms, the rapidity in warning of alarm and in investigating their causes, and the programme efficiency expressed as its cost-utility ratio.


Assuntos
Anormalidades Congênitas/epidemiologia , Vigilância da População , Sistema de Registros , Análise Custo-Benefício , Eficiência , Europa (Continente) , União Europeia , Humanos , Recém-Nascido , Mutagênicos , Sensibilidade e Especificidade , Software/economia , Teratogênicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA